Dr. Gordon Lithgow got in on the ground floor of aging research in the lab that discovered the first anti-aging mutation, age-1, and has spent the 25 ...
Rapamycin: An impressive geroprotector with a few potential flaws
If any drug has performed consistently and unequivocally well in anti-aging trials, it’s rapamycin. Dr. Matt Kaeberlein’s Dog Aging Project is among t...
Best friends forever: Matt Kaeberlein on helping dogs live longer
Dr. Matt Kaeberlein, an aging researcher and professor at the University of Washington, is the director of the Dog Aging Project. This two part progra...
Your DNA ages too: Genomic instability as a hallmark of aging
Part of the Hallmarks of Aging series. The cells in our bodies are constantly churning out proteins and other structures, built according to the bluep...
The hallmarks of aging, in plain English
Part of the Hallmarks of Aging series. Did you know you have two different ages? The obvious one is chronological age, or the number of years since yo...
Live slow, die old: Mounting evidence for caloric restriction in humans
Let’s say you wanted to hear a first-hand story of ordinary life 100 years ago. Where might you go to find a storyteller? Maybe you want to hear as ma...
Challenges of developing medicines for aging
Startups developing medicines to slow or prevent the diseases of aging all follow a similar three-step strategy. First they start from data generated ...
Welcome to the (Extracellular) Matrix
An interview with Dr. Collin Ewald Dr. Collin Ewald studies aging with the help of the roundworm C. elegans, an invertebrate with an already illustrio...
Interview with Linda Greensmith – A motor neuron expert
Linda Greensmith is a Professor at the Institute of Neurology (IoN), University College London (UCL) and a leading expert for motorneurons. She did h...